Feedback / Questions
Cosentyx (secukinumab) - Novartis
Cosentyx: Regulatory submission for nrAxSpA in 2019
(Novartis)
-
Jul 18, 2019 -
Q2 2019 Results: Regulatory submission for psoriatic arthritis in 2020
Regulatory
https://www.novartis.com/sites/www.novartis.com/files/q2-2019-ir-presentation.pdf
Jul 18, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious